← Open Payments lookup

RUBY WARD: Open Payments

NPI 1750335782 · FERRIDAY, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$546 in 31 payments from 8 companies in 2025. Trend: 2023 $576 · 2024 $233 · 2025 $546

Food & beverage: $546
CompanyPaymentsAmount
ABBVIE INC.12$146
Otsuka America Pharmaceutical, Inc.5$119
Axsome Therapeutics, Inc.5$110
Alkermes, Inc.3$49
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$40
Neurocrine BioSciences, Inc.1$33
E.R. Squibb & Sons, L.L.C.2$30
Supernus Pharmaceuticals, Inc.1$19

Products named: VRAYLAR, REXULTI, Auvelity, ARISTADA, CAPLYTA, INGREZZA, COBENFY, Qelbree.

Industry payments across LA — which companies pay providers there.